Celltrion Inc

XKRX:068270 (Korea (the Republic of))   Ordinary Shares
â‚© 188100.00 (+5.08%) Jun 4
69.36
P/B:
2.30
Market Cap:
â‚© 38.91T ($ 28.35B)
Enterprise V:
â‚© 40.16T ($ 29.26B)
Volume:
1.29M
Avg Vol (2M):
528.99K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Celltrion Inc ( XKRX:068270 ) from 2005 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Celltrion stock (XKRX:068270) PE ratio as of Jun 05 2024 is 69.36. More Details

Celltrion Inc (XKRX:068270) PE Ratio (TTM) Chart

To

Celltrion Inc (XKRX:068270) PE Ratio (TTM) Historical Data

Total 1278
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Celltrion PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-05 69.4 2024-03-28 67.8
2024-06-04 69.4 2024-03-27 49.0
2024-06-03 66.0 2024-03-26 49.6
2024-05-31 65.0 2024-03-25 50.3
2024-05-30 65.4 2024-03-22 50.1
2024-05-29 66.0 2024-03-21 49.4
2024-05-28 66.7 2024-03-20 48.7
2024-05-27 66.2 2024-03-19 49.1
2024-05-24 66.3 2024-03-18 48.5
2024-05-23 67.7 2024-03-15 48.1
2024-05-22 68.1 2024-03-14 47.7
2024-05-21 68.7 2024-03-13 47.6
2024-05-20 69.0 2024-03-12 48.3
2024-05-17 70.6 2024-03-11 47.8
2024-05-16 71.2 2024-03-08 48.0
2024-05-14 70.4 2024-03-07 47.1
2024-05-13 70.3 2024-03-06 48.0
2024-05-10 71.1 2024-03-05 46.8
2024-05-09 70.0 2024-03-04 46.9
2024-05-08 71.8 2024-02-29 47.8
2024-05-07 71.7 2024-02-28 50.5
2024-05-03 69.7 2024-02-27 50.6
2024-05-02 69.1 2024-02-26 48.3
2024-04-30 69.7 2024-02-23 47.9
2024-04-29 67.7 2024-02-22 47.0
2024-04-26 65.1 2024-02-21 47.1
2024-04-25 65.4 2024-02-20 47.9
2024-04-24 66.2 2024-02-19 48.5
2024-04-23 66.3 2024-02-16 48.5
2024-04-22 65.9 2024-02-15 48.7
2024-04-19 63.8 2024-02-14 49.0
2024-04-18 65.3 2024-02-13 49.9
2024-04-17 63.0 2024-02-08 47.8
2024-04-16 63.4 2024-02-07 47.6
2024-04-15 65.9 2024-02-06 48.7
2024-04-12 67.2 2024-02-05 48.1
2024-04-11 66.2 2024-02-02 49.0
2024-04-09 66.8 2024-02-01 47.5
2024-04-08 69.5 2024-01-31 47.8
2024-04-05 65.5 2024-01-30 47.8
2024-04-04 66.2 2024-01-29 48.3
2024-04-03 66.6 2024-01-26 48.5
2024-04-02 67.8 2024-01-25 48.4
2024-04-01 69.4 2024-01-24 48.1
2024-03-29 70.5 2024-01-23 48.3

Celltrion Inc (XKRX:068270) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.